SUBSEQUENT EVENTS (Details Narrative) - USD ($) |
1 Months Ended | |||
|---|---|---|---|---|
Sep. 13, 2022 |
Sep. 15, 2022 |
Jun. 30, 2022 |
Jun. 30, 2021 |
|
| Common Stock Issued | 30,000,000 | |||
| Common Stock Par Value | $ 0.001 | $ 0.001 | ||
| Aggregate Common Stock | 30,000,000 | |||
| Initial exercise price | $ 0.30 | |||
| Warrants percentagae | 100.00% | |||
| Offering Price | $ 0.30 | |||
| Description of september 15 amendment | the Company agreed to amend the terms of such Purchaser’s Warrants to purchase up to 15 million shares, effective as of August 30, 2022, to reduce the exercise price thereof to $0.001, subject to adjustment therein, and waive the “exploding feature” of the Anti-Dilution Provision in the Warrant that would otherwise have effected an increase in the number of warrant shares as a result of an exercise price reduction so as to result in the same aggregate value of the warrant shares multiplied by the exercise price. Additionally, other than an Exempt Issuance, as defined in the Warrants, from the date hereof until 90 days after the date hereof, neither the Company nor any subsidiary of the Company may issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents (as defined in the Warrants) | |||
| Subsequent Event [Member] | ||||
| Common Stock Issued | 50,000 | |||
| Description of september 13 amendment | the Company agreed to amend the terms of such Purchaser’s Warrants to purchase up to 15 million shares to provide effective as of June 29, 2022 reduce the exercise price thereof to $0.001, subject to adjustment therein, and waive the “exploding feature” of the Anti-Dilution Provision in the Warrant that would otherwise have effected an increase in the number of warrant shares as a result of an exercise price reduction so as to result in the same aggregate value of the warrant shares multiplied by the exercise price. Additionally, other than an Exempt Issuance, as defined in the Warrants, from the date hereof until 90 days after the date hereof, neither the Company nor any subsidiary of the Company may issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents (as defined in the Warrants) | |||
| Conversion of series B preferred stock | 190,000 | |||
| Common stock | 19,000,000 | |||
| Warrants exercised | 20,507,692 | |||
| Deposits | $ 500,000 |